60.1
AN2 Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
98.6
FY23:
111
FY24:
86.3
FY25:
59.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
5.21
FY22:
3.94
FY23:
28.2
FY24:
5.83
FY25:
2.01
Total assets
Change from FY21 to FY25
millions USD
FY21:
65.3
FY22:
103
FY23:
139
FY24:
92.1
FY25:
62.0
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.40
FY22:
7.19
FY23:
14.0
FY24:
10.2
FY25:
8.72
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.01
FY22:
0.00
FY23:
0
FY24:
0
FY25:
0.17
(positive)
Change from FY21 to FY25
millions USD
FY21:
−47.4
FY22:
95.4
FY23:
125
FY24:
81.8
FY25:
53.1
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
103
FY23:
139
FY24:
92.1
FY25:
62.0
All amounts in millions USD